STOCK TITAN
  1. Home
  2. News
  3. GEHC

GE HealthCare Technologies Inc. - GEHC STOCK NEWS

Welcome to our dedicated page for GE HealthCare Technologies news (Ticker: GEHC), a resource for investors and traders seeking the latest updates and insights on GE HealthCare Technologies stock.

GE HealthCare Technologies Inc. (NYSE: GEHC) is a leading global innovator in medical technology, pharmaceutical diagnostics, and digital solutions. The company operates through four main segments: Imaging, Ultrasound, Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Of these, the Imaging segment generates the majority of the company’s revenue.

GE HealthCare is dedicated to providing transformational medical technologies and services that enhance access to quality, affordable healthcare worldwide. Through its cutting-edge products and comprehensive solutions, the company aims to improve patient outcomes and streamline healthcare delivery.

Recent achievements include advancements in artificial intelligence (AI) integration within medical imaging, which supports more accurate and efficient diagnostics. The company is also involved in numerous partnerships with healthcare providers and research institutions to drive innovation and improve global healthcare standards.

Financially, GE HealthCare has showcased robust performance, with steady revenue growth and strong market presence. The company continuously invests in R&D to maintain its edge in the competitive healthcare industry. Their suite of products includes advanced imaging machines, ultrasound devices, patient monitoring systems, and contrast media for diagnostic imaging.

As part of a highly regulated industry, GE HealthCare adheres to strict compliance standards and maintains rigorous quality controls across its operations. The company actively engages with its community, although it reserves the right to monitor and manage public interactions to uphold professional and constructive discourse.

News

GE HealthCare Introduces AI-Enhanced Voluson Signature 20 and 18 Ultrasound Systems to Advance Women’s Health Imaging

Rhea-AI Summary
GE HealthCare introduces AI-enhanced Voluson Signature 20 and 18 ultrasound systems to advance women's health imaging. The new systems integrate AI, advanced tools, and an ergonomic design to improve image quality, speed up exams, and provide accurate diagnoses. Clinicians can now benefit from features like 'Hey Voluson' voice commands, SonoLyst for fetal anatomy identification, SonoPelvicFloor for pelvic floor assessments, Fibroid Mapping for fibroid documentation, and fetalHS for fetal heart assessments. These advancements aim to enhance patient care and streamline workflows in women's health settings.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.26%
Tags
AI
-
News

RSNA and GE HealthCare Bring Advanced Mammography Technology to Tanzania to Improve Access and Help Address Breast Cancer Mortality Rate

Rhea-AI Summary
RSNA and GE HealthCare collaborate to bring advanced mammography technology to Tanzania to improve breast cancer detection and treatment, aiming to lower the country's high mortality rate.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.29%
Tags
none
-
News

GE HealthCare to feature Mobile Mammography Screening Truck along with Latest AI Platform as part of SBI2024 Breast Cancer Imaging Showcase

Rhea-AI Summary
GE HealthCare to Showcase Latest Breast Cancer Detection Technology at SBI 2024 Symposium
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.19%
Tags
AI
News

GE HealthCare to Announce First Quarter 2024 Results on April 30, 2024

Rhea-AI Summary
GE HealthCare (Nasdaq: GEHC) will announce its Q1 2024 financial results on April 30, 2024. The management team will host a conference call and webcast. Investors can access the live webcast at https://investor.gehealthcare.com/news-events/events.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.88%
Tags
earnings
-
News

GE HealthCare Introduces Caption AI on Vscan Air SL Wireless Handheld Ultrasound System to Help More Clinicians Capture Diagnostic-Quality Cardiac Images

Rhea-AI Summary
GE HealthCare launches Caption AI on Vscan Air SL, an AI-driven software for rapid cardiac assessments, providing real-time guidance and automated ejection fraction estimation. The technology will debut at the 2024 American College of Cardiology Annual Scientific Session & Expo, aiming to improve cardiac care accessibility and early disease detection.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.04%
Tags
AI
-
News

GE HealthCare closes MIM Software acquisition, bolstering its portfolio and advancing its precision care strategy

Rhea-AI Summary
GE HealthCare acquires MIM Software to enhance its precision care strategy by integrating AI-enabled image analysis and workflow tools across multiple care areas, aiming to deliver more personalized, efficient, and connected care solutions. The addition of MIM Software's offerings strengthens GE HealthCare's response to provider needs, simplifying, streamlining, and automating essential tasks to enhance workflows.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.59%
Tags
acquisition
News

GE HealthCare Unveils AI-Enabled Urology Software Feature Prostate Volume Assist

Rhea-AI Summary
GE HealthCare (Nasdaq: GEHC) launches Prostate Volume Assist (PVA) urology-based AI software feature to automate prostate volume measurements, aiding in prostate imaging, biopsies, and treatment planning. PVA enhances workflow efficiency by providing quick, accurate prostate volume calculations critical for managing prostate diseases, including cancer. The AI technology supports urologists with precision care, available on bkActiv, bk3000/5000, and bkSpecto imaging systems globally.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.39%
Tags
AI
-
News

GE HealthCare Announces the FDA Clearance of nCommand Lite by IONIC Health

Rhea-AI Summary
GE HealthCare, listed on Nasdaq as GEHC, has secured exclusive distribution rights for IONIC Health's nCommand Lite technology, following FDA clearance. The system enables remote patient scanning support, image viewing, and real-time guidance from experts across various modalities. This move addresses the industry's staffing shortages and operational challenges, offering innovative solutions for healthcare providers.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.62%
Tags
clinical trial
-
News

GE HealthCare Announces Cash Dividend for First Quarter of 2024

Rhea-AI Summary
GE HealthCare Technologies Inc. (GEHC) announces a cash dividend of $0.03 per share of Common Stock for the first quarter of 2024, payable on May 15, 2024, to shareholders of record as of April 19, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.61%
Tags
dividends
News

GE HealthCare to Feature Latest Technologies in Interventional Radiology Focused on Precision Care at SIR 2024

Rhea-AI Summary
GE HealthCare to showcase Embo ASSIST AI solution at 2024 SIR Annual Scientific Meeting, offering precision care delivery for vascular diseases. The solution helps reduce patient dose, fluoroscopy time, and overall procedure time during prostate artery embolization.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.61%
Tags
none

FAQ

What is the current stock price of GE HealthCare Technologies (GEHC)?

The current stock price of GE HealthCare Technologies (GEHC) is $82.44 as of November 22, 2024.

What is the market cap of GE HealthCare Technologies (GEHC)?

The market cap of GE HealthCare Technologies (GEHC) is approximately 36.9B.

What does GE HealthCare Technologies Inc. do?

GE HealthCare Technologies Inc. provides transformative medical technologies, pharmaceutical diagnostics, and digital solutions to improve healthcare access and quality globally.

What are the main business segments of GE HealthCare?

The main business segments are Imaging, Ultrasound, Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx).

How does GE HealthCare generate most of its revenue?

The company generates the majority of its revenue from the Imaging segment.

What recent advancements has GE HealthCare made?

GE HealthCare has made significant advancements in AI integration within medical imaging, improving diagnostic accuracy and efficiency.

Who are GE HealthCare's partners?

The company collaborates with healthcare providers and research institutions to drive innovation and improve healthcare standards.

How does GE HealthCare ensure compliance?

GE HealthCare adheres to strict regulatory compliance standards and maintains rigorous quality controls across its operations.

What products does GE HealthCare offer?

GE HealthCare offers a range of products, including imaging machines, ultrasound devices, patient monitoring systems, and diagnostic contrast media.

What is GE HealthCare's commitment to the community?

The company engages actively with its community and strives to maintain professional and positive interactions while monitoring public posts and conversations.

How has GE HealthCare performed financially?

GE HealthCare has shown robust financial performance with steady revenue growth, supported by continuous investment in research and development.

What is GE HealthCare's mission?

GE HealthCare is committed to improving patient outcomes and making quality healthcare more accessible and affordable worldwide.

Stock GEHC logo
GE HealthCare Technologies Inc.

Nasdaq:GEHC

GEHC Rankings

#354 Ranked by Market Cap
#2112 Ranked by Dividends

GEHC Stock Data

36.94B
442.78M
3.09%
83.51%
1.81%
Health Information Services
X-ray Apparatus & Tubes & Related Irradiation Apparatus
Link
United States of America
CHICAGO